The goal for the multiyear partnership is to make genetic analysis a routine part of patient care.
Digital health incubator Rock Health released data today that shows an increase in funding for med-tech startups in the first quarter of 2013.
Bina's platform significantly reduces the time and cost of processing the human genome, which has far-reaching implications for the world of healthcare.
Guest Post Genomics data is about to change the way doctors discover and treat disease -- but there are some significant obstacles standing in the way.
The cost of sequencing the human genome has plummeted. But how will this benefit doctors and patients?
A new cancer discovery puts the emerging field of genomics on the map, may speed up the drug approval process, and de-risks groundbreaking research for venture-funded biotech companies.
TODAY’S HEADLINES:
Trius Therapeutics raises $30M for new antibiotics (release)
Genomas gets $1.2M grant for genomic side-effect tests (release)
Provasculon receives $500K, enters Biogen Idec incubator (VentureWire)
Animal diagnostics firm Quadraspec aims for $5M round (VentureWire)
MPM Capital names two
…
TODAY’S HEADLINES:
Adnavance pulls in C$3.7M for molecular diagnostics, names new CEO (release)
“Personalized medicine” co. Proprius sells to Cypress Bio for up to $75M (release)
Vaccinex raises $25M in wake of GSK deal for antibody drugs (VentureWire)
Cianna Medical
…
(UPDATED: See below.)
As I discussed a few weeks ago with respect to deCODEme — a “personal genomics” service hurriedly launched last November by Iceland’s deCODE Genetics in an apparent attempt to beat 23andMe to market (it succeeded by …
TODAY’S HEADLINES:
Compact ultrasound maker Zonare Medical raises $30M (VentureWire)
TherOx raises $30M for hypersaturated-oxygen devices (peHUB)
Accumetrics, antiplatelet-drug diagnostic maker, raises $29M (release)
Population Genetics takes in £3.8M for massively parallel genome studies (GenomeWeb)
“Brain fitness” trainer Dakim raises
…
23andMe held its official launch today, as expected, and in the process managed to address a few of the nagging questions that remained after I reviewed its service over the weekend. “Addressed” is definitely the operative word here, though, because …
Medical treatment that’s tailored to your individual genetic profile — “personalized medicine,” for short — has been a long, long time in coming, as I’ve noted here and here. Part of the reason, of course, is that personalizing medicine cuts …
Featured companies: Aldagen, LDR, Lyten Endoscopy, MachLabs, Permatox, TeleMedicine Clinic, ThromboVision
Spinal-implant maker LDR raises $25M — Austin, Texas-based LDR, a maker of spinal implants, raised $25 million in a third funding round. Investors included Telegraph Hill Partners, Austin Ventures, …
(UPDATED at 11am PT on Sunday, 8/26/07: See below.)
Featured companies: Clinical Data, Epidauros Biotechnologie, Precision Therapeutics, UMD, Zars Pharma
UMD to close $8M for menstrual pain and osteoporosis — Cincinnati’s UMD, a developer of vaginal drug-delivery technologies, expects …
(UPDATED: See below.)
Personalized medicine — the idea that doctors will one day tailor your medical care based on your genetic profile — has been a long time coming, as I’ve previously written. As it turns out, that’s no …
(UPDATED: See below.)
For at least a decade, biotech futurists have been predicting that the genomics revolution will lead to medical treatments tailored to the genetic quirks of individuals. And for at least as long, we’ve all been waiting …
